Complement activation in patients with COVID-19: A novel therapeutic target-Reference-Cited by-同舟云学术

Complement activation in patients with COVID-19: A novel therapeutic target

Published:2020-07 Issue:1 Volume:146 Page:215-217
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Cugno Massimo,Meroni Pier Luigi,Gualtierotti Roberta,Griffini Samantha,Grovetti Elena,Torri Adriana,Panigada Mauro,Aliberti Stefano,Blasi Francesco,Tedesco Francesco,Peyvandi Flora

Funder

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference9 articles.

1. Clinical characteristics of coronavirus disease 2019 in China;Guan;N Engl J Med,2020

2. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019;Chen;J Clin Invest,2020

3. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches;Riedl;Semin Thromb Hemost,2014

4. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis;Gralinski;mBio,2018

5. Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [published online ahead of print April 10, 2020]. medRxiv. https://doi.org/10.1101/2020.03.04.20031120.

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies;Journal of Autoimmunity;2024-09

2. A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19;Antiviral Research;2024-09

3. Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions;International Journal of Molecular Sciences;2024-06-29

4. Revisiting the interaction between complement lectin pathway protease MASP-2 and SARS-CoV-2 nucleoprotein;Frontiers in Immunology;2024-06-07

5. Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling;Biofabrication;2024-06-05